Phase 2 study of pembrolizumab alone or combined with acalabrutinib in platinum-refractory metastatic urothelial carcinoma (mUC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Zhang, T; Harrison, M; O'Donnell, P; Alva, A; Hahn, N; Appleman, LJ; Cetnar, J; Burke, J; Fleming, M; Milowsky, M; Mortazavi, A; Shore, N; Schmidt, EV; Kresja, C; Chen, T; Bitman, B; Izumi, R; Hamdy, A; George, DJ

Published Date

  • September 1, 2017

Published In

Volume / Issue

  • 28 /

Published By


  • 2

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • September 8, 2017

Conference End Date

  • September 12, 2017